Insulin-treated Zucker diabetic fatty rats retain the hypertriglyceridemia associated with obesity

Metabolism: Clinical and Experimental

Volumn 49, Issue 11, 2000, Pages 1424-1430

  Sparks, Janet D ^a,b   Shaw, Walter N ^a,b   Corsetti, James P ^a,b   Bolognino, Mary ^a,b   Pesek, Joseph F ^a,b   Sparks, Charles E ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b Genetic Models Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN C; APOLIPOPROTEIN E; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; INSULIN ZINC SUSPENSION; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADOLESCENT; AGAR GEL ELECTROPHORESIS; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; INSULIN TREATMENT; LIPOPROTEIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; WEIGHT GAIN;

EID: 0033756540     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2000.17736     Document Type: Article

References (29)

1. Intensive insulin therapy for patients with type II diabetes
2. The diabetic Zucker fatty rat
3. Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes mellitus
4. Defective fatty acid-mediated β-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes
5. Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: An alteration not due to hyperglycemia
6. D-glucose. UV-methods with hexokinase and glucose-6-dehydrogenase
7. Enzymatic determination of total serum cholesterol
8. A peroxidase-coupled method for the colorimetric determination of serum triglycerides
9. Practical methods for plasma lipoprotein analysis
10. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples
11. Cleavage of structural proteins during the assembly of the head of bacteriophage T 4
12. Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes
13. Liver regrowth and apolipoprotein B secretion by rat hepatocytes following partial hepatectomy
14. Lipoprotein alterations in 10 and 20 week old Zucker diabetic fatty rats: Hyperinsulinemic versus insulinopenic hyperglycemia
15. Hepatic secretion of lipoproteins in the rat and the effect of experimental nephrosis
16. The production and utility of monoclonal antibodies to rat apolipoprotein B lipoproteins
17. Plasma very low density lipoproteins contain a single molecule of apolipoprotein B
18. Chromatographic method for isolation and quantification of apolipoproteins B-100 and B- 48
19. Regulation of hepatic apolipoprotein B RNA editing in the genetically obese Zucker rat
20. Contributions of fatty acid and sterol synthesis to triglyceride and cholesterol secretion by the perfused rat liver in genetic hyperlipemia and obesity
21. Characterization of the plasma lipoproteins of the genetically obese hyperlipoproteinemic Zucker fatty rat
22. Lipoproteins in the plasma and hepatic perfusates of the Zucker fatty rat
23. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice
24. Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B 48 remnants that is corrected by excess apolipoprotein E
25. Effects of glucose and insulin on rat apolipoprotein A-I gene expression
26. Diabetic dyslipidemia: Pathology and treatment
27. Hypolipidemic agents: Their role in diabetes mellitus
28. Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-dependent diabetes
29. Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species. Relation to atherogenesis susceptibility